PR Newswire
AbbVie to Feature New Data at ASH 2025 Showcasing Continued Advances Across Novel Treatment Modalities in Multiple Blood Cancers
📈
AI Sentiment
Highly Positive
8/10
AbbVie Inc. News
Latest updates and market news for ABBV
16 news
Nov 26 - Dec 2, 2025
Page 1
MT Newswires
Amneal Pharmaceuticals Wins FDA Approval for Generic Restasis, Plans Q1 Rollout
📊
AI Sentiment
Positive
6/10
GlobeNewswire
Amneal Announces U.S. FDA Approval of Cyclosporine Ophthalmic Emulsion 0.05%
📈
AI Sentiment
Highly Positive
8/10
Benzinga
If You Invested $10K In AbbVie Stock 10 Years Ago, How Much Would You Have Now?
📈
AI Sentiment
Highly Positive
8/10
Simply Wall St.
AbbVie (NYSE:ABBV) Will Pay A Larger Dividend Than Last Year At $1.73
âž–
AI Sentiment
Neutral
5/10
Motley Fool
3 High-Yielding Dividend Growth Stocks That Can Generate Passive Income for Your Portfolio for Years
📈
AI Sentiment
Highly Positive
8/10
Simply Wall St.
Assessing AbbVie’s (ABBV) Valuation: Is There More Upside After Recent Performance?
📈
AI Sentiment
Highly Positive
8/10
MT Newswires
Sector Update: Health Care Stocks Decline Friday Afternoon
âž–
AI Sentiment
Neutral
5/10
MT Newswires
AbbVie's Skyrizi Wins Positive Reimbursement Recommendation for Ulcerative Colitis in Canada
📊
AI Sentiment
Positive
7/10
GlobeNewswire
SKYRIZI® (risankizumab) Receives Positive Reimbursement Recommendation by Canada’s Drug Agency for Ulcerative Colitis and AbbVie Concludes Letter of Intent with the pan-Canadian Pharmaceutical Alliance
📈
AI Sentiment
Highly Positive
8/10
Zacks
IRWD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Pick?
📊
AI Sentiment
Positive
7/10
Barrons.com
Enterprise Software, Health Care Stocks Miss Out on Broader Rally
âž–
AI Sentiment
Neutral
4/10
MT Newswires
Centers for Medicare & Medicaid Services Unveils $12 Billion Net Savings From Reduction in Drug Prices
âž–
AI Sentiment
Neutral
5/10
Share this news page